We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$335M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$140M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$82.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.4M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EOLS icon
4251
Evolus
EOLS
$551M
$9.59K ﹤0.01%
1,319
+359
+37% +$3.1K
CPUH.U
4252
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
$9.57K ﹤0.01%
889
-400
-31% -$4.22K
APLT
4253
DELISTED
Applied Therapeutics
APLT
$9.57K ﹤0.01%
7,480
+672
+10% +$891
MBI icon
4254
MBIA
MBI
$253M
$9.57K ﹤0.01%
1,108
-213
-16% -$1.92K
HARP
4255
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$9.56K ﹤0.01%
1,347
+324
+32% +$2.24K
CNSY
4256
Cerenome, Inc. Common Stock
CNSY
$26.4M
$9.56K ﹤0.01%
189
+165
+688% +$15.4K
XMAX
4257
XMAX Inc
XMAX
$594M
$9.56K ﹤0.01%
4,266
+2,085
+96% +$5.54K
AGIL
4258
DELISTED
AgileThought Inc
AGIL
$9.55K ﹤0.01%
+12,730
New +$16.8K
CDZI icon
4259
Cadiz
CDZI
$299M
$9.54K ﹤0.01%
2,351
-533
-18% -$2.35K
TSHA icon
4260
Taysha Gene Therapies
TSHA
$2.14B
$9.54K ﹤0.01%
14,435
+7,180
+99% +$5.2K
UHG
4261
DELISTED
United Homes Group
UHG
$9.54K ﹤0.01%
855
-1,985
-70% -$23.4K
BKTI icon
4262
BK Technologies
BKTI
$290M
$9.54K ﹤0.01%
576
+425
+281% +$5.96K
RIBT
4263
DELISTED
RiceBran Technologies
RIBT
$9.54K ﹤0.01%
8,592
-2,458
-22% -$2.35K
VWOB icon
4264
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.22B
$9.53K ﹤0.01%
153
+125
+446% +$7.7K
TNGX icon
4265
Tango Therapeutics
TNGX
$4.44B
$9.53K ﹤0.01%
2,869
-10,454
-78% -$37.6K
FV icon
4266
First Trust Dorsey Wright Focus 5 ETF
FV
$3.78B
$9.52K ﹤0.01%
+203
New +$9.05K
HYLB icon
4267
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.47B
$9.52K ﹤0.01%
276
+1
+0.4% +$34
MGOL
4268
DELISTED
MGO Global Inc. Common Stock
MGOL
$9.52K ﹤0.01%
427
+164
+62% +$2.43K
CELZ icon
4269
Creative Medical Technology
CELZ
$8.04M
$9.52K ﹤0.01%
2,053
+1,130
+122% +$6.55K
SIF icon
4270
SIFCO Industries
SIF
$130M
$9.5K ﹤0.01%
3,862
+190
+5% +$513
CNTX icon
4271
Context Therapeutics
CNTX
$42.8M
$9.5K ﹤0.01%
5,937
-2,906
-33% -$2.47K
VUZI icon
4272
Vuzix
VUZI
$220M
$9.5K ﹤0.01%
1,862
-264
-12% -$1.17K
BWX icon
4273
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$9.49K ﹤0.01%
421
+420
+42,000% +$9.56K
ACRV icon
4274
Acrivon Therapeutics
ACRV
$74M
$9.49K ﹤0.01%
732
-360
-33% -$4.36K
EWTX icon
4275
Edgewise Therapeutics
EWTX
$4.81B
$9.48K ﹤0.01%
1,223
-15,177
-93% -$128K
169 170
171
172 173

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.